These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9730598)
1. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases. Luan X; Ramesh KH; Cannizzaro LA Cytogenet Cell Genet; 1998; 81(3-4):183-8. PubMed ID: 9730598 [TBL] [Abstract][Full Text] [Related]
2. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
3. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816 [TBL] [Abstract][Full Text] [Related]
4. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464 [TBL] [Abstract][Full Text] [Related]
5. Frequent aberration of FHIT gene expression in acute leukemias. Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330 [TBL] [Abstract][Full Text] [Related]
6. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma. Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140 [TBL] [Abstract][Full Text] [Related]
7. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
8. Structure and expression of the human FHIT gene in normal and tumor cells. Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482 [TBL] [Abstract][Full Text] [Related]
9. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676 [TBL] [Abstract][Full Text] [Related]
10. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
11. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157 [TBL] [Abstract][Full Text] [Related]
13. Decreased or altered expression of the FHIT gene in human leukemias. Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214 [TBL] [Abstract][Full Text] [Related]
14. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells. MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543 [TBL] [Abstract][Full Text] [Related]
15. FHIT mutations in human primary gastric cancer. Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression and deletion of FHIT gene in leukemias. Wang L; Dong LJ; Tian F; Liu GX; Li CH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737 [TBL] [Abstract][Full Text] [Related]
17. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Mao L; Fan YH; Lotan R; Hong WK Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
19. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration]. Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436 [TBL] [Abstract][Full Text] [Related]
20. Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells. Carapeti M; Aguiar RC; Sill H; Goldman JM; Cross NC Br J Cancer; 1998 Sep; 78(5):601-5. PubMed ID: 9744498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]